Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 10:40 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | SINGER JAMES R | 5,000,000 8.1% | 2,535,000 (+102.84%) | View |
| 2022-01-24 08:22 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | SINGER JAMES R | 2,465,000 5.1% | 2,465,000 (New Position) | View |
| 2021-01-05 3:12 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | SINGER JAMES R | 3,000,000 4.7% | 150,000 (+5.26%) | View |
| 2020-03-27 08:56 am Purchase | 13G | OVID THERAPEUTICS INC OVID | SINGER JAMES R | 2,850,000 5.2% | 495,000 (+21.02%) | View |
| 2020-01-17 4:01 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | SINGER JAMES R | 2,355,000 4.9% | 985,000 (+71.90%) | View |
| 2020-01-17 3:57 pm Sale | 13G | ADURO BIOTECH, INC ADRO | SINGER JAMES R | 3,200,000 4% | -1,058,000 (-24.85%) | View |